SCHEMBL6070520

SCHEMBL6070520

O=C(NCc1ccncc1)c1cccc2[nH]c3c(c12)CCc1cn[nH]c1-3

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK10 P53779 13/20 0.53
RIPK1 Q13546 11/20 0.53
KDM4E B2RXH2 3/20 0.46
MEN1 O00255 3/20 0.46
ALDH1A1 P00352 3/20 0.46
LMNA P02545 3/20 0.46
MAPT P10636 3/20 0.46
KMT2A Q03164 3/20 0.46
HSD17B10 Q99714 3/20 0.46
TSHR P16473 2/20 0.46
RAB9A P51151 2/20 0.46
AURKA O14965 1/20 0.46
HPGD P15428 1/20 0.46
PTK2B Q14289 1/20 0.46
MAPK1 P28482 4/20 0.43
POLB P06746 1/20 0.41
NPC1 O15118 1/20 0.40
MPI P34949 1/20 0.40
KDR P35968 1/20 0.40
MMP13 P45452 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6070749 0.92 MAPK10 (0.55) MAPK10RIPK1KDM4EMEN1ALDH1A1
SCHEMBL6071003 0.86 MAPK10 (0.57) MAPK10RIPK1KDM4EMEN1ALDH1A1
SCHEMBL6071378 0.84 MAPK10 (0.60) MAPK10RIPK1KDM4EMEN1ALDH1A1
SCHEMBL6070597 0.84 MAPK10 (0.55) MAPK10RIPK1KDM4EMEN1ALDH1A1
SCHEMBL6070403 0.84 SHMT2 (0.54) MAPK10RIPK1KDM4EMEN1ALDH1A1
SCHEMBL6071278 0.83 MAPK10 (0.54) MAPK10RIPK1KDM4EMEN1ALDH1A1
SCHEMBL6070893 0.82 MAPK10 (0.53) MAPK10RIPK1KDM4EMEN1ALDH1A1
SCHEMBL6071195 0.82 MAPK10 (0.53) MAPK10RIPK1KDM4EMEN1ALDH1A1
SCHEMBL6071046 0.82 MAPK10 (0.58) MAPK10RIPK1KDM4EMEN1ALDH1A1
SCHEMBL6071528 0.81 MAPK10 (0.51) MAPK10RIPK1KDM4EMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060264493-A1 Tetracyclic pyrazole derivatives as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them PFIZER ITALIA S.R.L. (IT) 2006-11-23 US claimed
US-20060264493-A1 Tetracyclic pyrazole derivatives as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them PFIZER ITALIA S.R.L. (IT) 2006-11-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060264493-A1 Tetracyclic pyrazole derivatives as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them MAP3K1, MAP3K19, MAP3K20 MAPK10 387/4885RIPK1 131/4885KDM4E 1799/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.